4//SEC Filing
MENDLEIN JOHN 4
Accession 0001209191-23-004237
CIK 0001434316other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:14 PM ET
Size
6.6 KB
Accession
0001209191-23-004237
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Exercise/Conversion
Common Stock
2023-01-19$1.37/sh+28,461$38,992→ 311,231 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-01-19+28,461→ 0 totalExercise: $1.37Exp: 2023-02-06→ Common Stock (28,461 underlying)
Footnotes (1)
- [F1]This stock option is fully vested and exercisable.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001238362
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:14 PM ET
- Size
- 6.6 KB